EMA validates marketing authorisation application for efanesoctocog alfa for treatment of haemophilia A

/PRNewswire/ -- Sobi today announced that the European Medicines Agency (EMA) has accepted and validated a marketing authorisation application for...

Related Keywords

Stockholm ,Sweden ,Australia ,Russia ,United States ,America ,Prnewswire Sobi ,Tony Hoos ,Linkedin ,Head Of Research Development ,Sobi Investor Relations Team ,Youtube ,Nasdaq ,Euronext ,European Medicines Agency ,Drug Administration ,Chief Medical ,North Africa ,Middle Eastern ,North America ,Middle East ,Sobi Media ,Orphan Biovitrum ,Swedish Orphan Biovitrum Ab ,Medical Pharmaceuticals ,Health Care Amp Hospitals ,Pharmaceuticals ,Biotechnology ,Licensing ,New Products Amp Services ,